Advocates Webinar: Modernizing Oncology Endpoints
2026-02-19 12:00 - 13:00 (America/Halifax)
The Advocates Webinar: Modernizing Oncology Endpoints, hosted virtually by Friends of Cancer Research (Friends), is a free, advocates-focused session scheduled for Thursday, February 19, 2026, from 12:00 PM to 1:00 PM ET.
The webinar will build upon the public meeting held earlier in the month, focusing on translating complex scientific and policy discussions into accessible, advocacy-focused insights concerning two emerging tools in cancer drug development: circulating tumor DNA (ctDNA) and Artificial Intelligence (AI)-based tumor assessment tools. The goal is to explain how these biomarkers and technologies can accelerate evidence generation and clinical trial efficiency to support earlier patient access to treatments.
Register.

Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care
2026-02-19 19:00 - 20:00 (America/New_York)
The Multinational Association of Supportive Care in Cancer (MASCC), in partnership with SIOG-NAHS and JASCC Geriatrics, will host a webinar titled “Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care“.
Scheduled for Thursday, February 19, 2026, the session runs from 7:00 PM to 8:00 PM EST. The agenda includes discussions on geriatric assessment in Japan and evidence-based integrative medicine, featuring a panel led by co-chairs Dr. Ayumu Matsuoka and Dr. Sriram Yennu, alongside Dr. Lisa Guccione and Dr. Kelly McConnell.

APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit
2026-02-20 - 2026-02-21 | Circa Resort & Casino, 8 Fremont St, Las Vegas, NV, 89101, United States
The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME, scheduled for February 20th – 21st, 2026, at the Circa Resort and Casino in Las Vegas, Nevada.
The summit is specifically tailored for Advanced Practice Providers (APPs), including Nurse Practitioners (NPs), Physician Assistants (PAs), pharmacists, and nurses, with the primary goal of providing the latest evidence-based strategies to optimize care and outcomes for patients with cancer.
Register.

Highlights in GI Oncology
2026-02-20 - 2026-02-21 | Orlando World Center Marriott, 8701 World Center Dr, Orlando, FL, 32821, United States
The Highlights in GI Oncology conference, hosted by Horizon CME, is a two-day educational program providing the latest science and practice-changing advances from the world’s premier GI oncology event, the ASCO Gastrointestinal Cancers Symposium.
The CME initiative, designed for a multidisciplinary audience including oncologists, surgeons, and nurses, is scheduled for February 20–21, 2026, at the Orlando World Center Marriott. Expert faculty will review the most recent research and treatment strategies for various GI cancers, including colorectal, pancreatic, biliary, and neuroendocrine cancers, applying the findings to patient case contexts.
Register.

Oncology APP Leadership Forum 2026
2026-02-20 - 2026-02-21 | Circa Resort & Casino, 8 Fremont St, Las Vegas, NV, 89101, United States
The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders, managers, administrators, and directors in oncology.
Scheduled for February 20–21, 2026, at the Circa Resort and Casino in Las Vegas, the forum focuses on equipping APP leaders with the knowledge and skills to become more effective leaders in their organizations. Key topics on the agenda include critical conversations in the workplace, utilizing AI in leadership, constructing an APP billing dashboard, building leadership education frameworks, and a workshop on burnout and boundary setting.
Register.

5th CECOG Breast Cancer Academy
2026-02-20 - 2026-02-21 | ARCOTEL AQ, Althanstraße 8, Vienna, Vienna, 1090, Austria
The 5th CECOG Breast Cancer Academy, organized by the Central European Cooperative Oncology Group (CECOG), is a specialized educational event taking place on February 20-21, 2026, in Vienna, Austria.
Held at the ARCOTEL AQ, the academy is designed for oncology professionals to explore current standards and emerging challenges in both early and advanced breast cancer management. Led by a scientific committee of Austrian experts, the program features expert-led sessions on clinical scenarios and offers CME accreditation to enhance the professional development of its participants.

CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia - Resonance
2026-02-20 09:00 - 10:00 (America/New_York)
The ALRCaN Global webinar, titled “CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia,” is scheduled for Friday, February 20, 2026, at 09:00 AM ET. Featuring Dr. Hannah Lust, the session will focus on the evolving treatment landscape for Adolescent and Young Adult (AYA) patients, specifically examining the transition and relationship between CAR T-cell therapy and hematopoietic stem cell transplantation.
Hosted by Resonance Health and created by Ivana Cáceres, the event is supported by the leadership of Scott Howard, Stacy Cooper, Archie Bleyer, and Dan Douer. This discussion provides a global forum for oncology professionals to explore integrated therapeutic strategies aimed at optimizing long-term outcomes for the AYA leukemia population.

16th World ADC London
2026-02-23 - 2026-02-26 | ExCeL London, One Western Gateway, Royal Victoria Dock, London, E16 1XL, United Kingdom
﻿The 16th World ADC London, set to convene at ExCeL London from February 23–26, 2026, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 event is differentiation across the ADC value chain – from design to production – in response to the dominance of Topo1 and MMAE payloads and the rising threat of resistance.
The summit will host over 800 senior European ADC decision-makers, including biopharma executives, clinicians, investors, and regulators. The comprehensive agenda features five streams covering the entire lifecycle of ADCs, specifically highlighting novel cytotoxic and non-cytotoxic payloads, dual/bispecific ADCs, non-antibody conjugates, and strategies for advancing these targeted therapies into earlier-line oncology treatments for maximum patient impact.
The 16th World ADC London event is expected to feature 800+ ADC Industry Attendees representing 240+ Companies in the Room, with presentations delivered by a 120+ Global Speaker Faculty. The agenda includes 14+ Hours of Networking, offering comprehensive One-on-One Partnering and informal networking opportunities, spread across 4 Days of ADC Insights. The content is organized into 5 Tracks of End-to-End ADC Content.
View the 2026 agenda here.
Registration link.
Full Event Guide link.
You can find more posts on ADCs on OncoDaily.

Innovations and Clinical Advances in Radioligand Therapy
2026-02-24
The OncoCorner webinar, titled “Innovations and clinical advances in radioligand therapy,” is scheduled for Tuesday, February 24, 2026, starting at 18:00 CET. This session explores the rapid evolution of Radioligand Therapy (RLT), focusing on how translational research is enhancing targeting precision and integrating nuclear medicine more deeply into modern oncology.
Participants will gain insights into current capabilities at leading cancer centers, expected breakthroughs over the next several years, and the most promising emerging agents in the RLT landscape. The event features an expert panel consisting of Antoine Leimgruber, Saverio Braccini, Anne-Laure Giraudet, and Niklaus Schaefer, and is supported by Sharing Progress in Cancer Care (SPCC) as part of its Sustaining Corporate Programme.

Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond
2026-02-24 - 2026-02-25 | Shinjuku
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, 2026.
The two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy, spanning from basic research to clinical applications, with a strong emphasis on addressing resistance – a common challenge in current cancer treatment.
The program will feature invited talks from leading scientists on innovative therapeutic strategies, including novel NK, T, and myeloid cell therapies, mRNA therapies, cytokine targeting, and new combinatorial immune checkpoint blockade strategies.

9th CAR-TCR Summit Europe 2026
2026-02-24 - 2026-02-26 | Park Plaza Victoria London, 239 Vauxhall Bridge Road, London, Greater London (England), SW1V 1EQ, United Kingdom
The 9th CAR-TCR Summit Europe 2026 is the essential, industry-dedicated forum for next-generation cell therapy, scheduled from February 24–26, 2026, in London, UK, at the Park Plaza Victoria hotel. Organized by Hanson Wade, the summit unites developers from Europe and Asia with an end-to-end focus on accelerating clinical success by exploring cutting-edge scientific insights and practical strategies, including novel CAR, TCR, NK, and Macrophage designs, engineering to improve durability, and solutions to overcome bottlenecks in manufacturing, regulatory approval, and commercialization.
Full Event Guide Link.
This article is sponsored by Hanson Wade Group.

Colorectal Liver Metastasis Consensus Conference
2026-02-24 - 2026-02-26 | TMC3 Collaborative Building, 7255 Helix Park Ave, Houston, TX, 77030, United States
The Colorectal Liver Metastasis Consensus Conference, based on the Danish-Zurich model, is a three-day in-person conference dedicated to advancing care, research, and building consensus for the treatment of colorectal liver metastases. Scheduled from Tuesday, February 24, to Thursday, February 26, 2026, the meeting will be held at the TMC3 Collaborative Building (7255 Helix Park Ave.) in Houston, Texas.
Hosted by The University of Texas MD Anderson Cancer Center, the primary goal is to establish guidelines for the treatment of and research related to colorectal cancer liver metastases, culminating in a consensus statement brought forth by leading experts, clinicians, and researchers in the field.
Register.

Data-Driven Cancer Research Conference
2026-02-24 - 2026-02-26 | Edinburgh International Conference Centre (EICC), 150 Morrison St, Edinburgh, EH3 8EE
The Data-Driven Cancer Research Conference is a comprehensive three-day scientific event hosted by Cancer Research UK in partnership with the EACR (European Association for Cancer Research), scheduled for February 24–26, 2026.
Set in the historic city of Edinburgh, the conference explores the intersection of data science and oncology, featuring expert-led discussions on AI-accelerated early detection, digital twins, and inclusive precision medicine. The program aims to foster global collaboration among bioinformaticians, computational oncologists, and researchers to address shared challenges in patient data transparency and pediatric cancer.
Register.

ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026
2026-02-25
The ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases.
The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion will focus on the complexities and evolving areas of practice, such as optimal biomarker testing, the integration of immunotherapy, and the management of treatment-related toxicities.
Register.

British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop
2026-02-25 | Friends House in Euston, 173-177 Euston Rd., London, NW1 2BJ, United Kingdom
The British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop is scheduled for Wednesday, February 25, 2026, in London.
This face-to-face event is designed for members of the haematology community with a specialist interest in supportive care – ranging from pain and infection management to psychological and social support – to meet and network in person. The primary objective of the workshop is to collaborate on developing the SIG’s strategy for the coming years, ensuring that multidisciplinary expertise continues to improve education, training, and clinical practice for patients with blood disorders across the UK.
Chaired by Laura Miller, the SIG committee includes a diverse group of professionals such as Shireen Kassam, Priya Sriskandarajah, and Jennifer Vidrine, who will lead discussions on embedding high standards of supportive care throughout the patient treatment pathway.

62nd Annual Scientific Conference of the Irish Association for Cancer Research (IACR)
2026-02-25 - 2026-02-27 | Galway Bay Hotel, Salthill Road Lower, Salthill, Galway, County Galway, H91 W295, Ireland
The 62nd Annual Scientific Conference of the Irish Association for Cancer Research (IACR) is a prominent gathering of the Irish cancer research community, scheduled for February 25–27, 2026. Taking place at the Galway Bay Hotel in Salthill, Galway, the conference serves as a multidisciplinary platform for clinicians, basic scientists, and nursing professionals to discuss the latest advancements in oncology.
Key themes for the 2026 meeting include digital and connected health applications, liquid biopsies for disease monitoring, and advanced tumor models. The event also highlights excellence in communication through the Patrick G. Johnston Award for Excellence in Cancer Research Outreach, which encourages early-stage researchers to present their work to lay audiences, bridging the gap between high-level science and public understanding.
Register.

EnVision Summit 2027
2026-02-25 08:00 - 17:00 (America/Halifax) | Hyatt Regency Grand Reserve, 200 Coco Beach Blvd., Río Grande, Puerto Rico, 00745, United States
The EnVision Summit 2027 is a premier multispecialty ophthalmology and optometry meeting scheduled for February 12–15, 2027, at the Hyatt Regency Grand Reserve Puerto Rico.
Created by physicians for physicians, the summit breaks the traditional conference mold by offering a family-friendly “one-stop-shop” for CME and COPE credits in a relaxed, resort setting. The 2027 program will feature dedicated tracks for cataract and refractive surgery, glaucoma management, retina, and ocular surface disease, with a strong emphasis on the clinical integration of Artificial Intelligence (AI) and multidisciplinary co-management. Unique to this event, the complimentary Youth Track provides interactive programs for children while parents attend lectures, ensuring a professional development experience that enhances work-life balance without sacrificing academic rigor.
Register now.

2nd Pediatric and Neonatal Palliative Care Symposium
2026-02-25 10:30 - 16:30 (America/Halifax) | Fondation Charles Corm, Corm Building, Beirut, Lebanon
The 2nd Pediatric and Neonatal Palliative Care Symposium 2026, organized by the CHANCE Association and endorsed by the Lebanese Association for Palliative Care Nursing, will take place on February 25 at Fondation Charles Corm in Ashrafieh, Beirut.
The scientific program begins at 11:00 AM, featuring a keynote by Professor Julia Downing of the International Children’s Palliative Care Network on global perspectives in children’s palliative care. Sessions will focus on prenatal and neonatal palliation, pediatric pain management, innovation including virtual reality, and a national panel assessing the current landscape of pediatric palliative care in Lebanon.
At 3:30 PM, the event transitions to the Closing Event of the National Pioneer Project, held under the patronage and in the presence of H.E. Minister of Public Health Dr. Rakan Nassereddine. Prof. Roula Farah, President of CHANCE Association, will formally present “Innovation and Immersive Technology in Pediatric Pain, Psycho-Oncology and Palliative Care: Impact, Voices, and the Path Forward.” The ceremony will highlight project outcomes, children and parents’ testimonials, and recognition of psychologists and hospital partners who contributed to advancing pediatric psycho-oncology and palliative services nationwide.
Register now.
RSVP: Confirm your attendance by calling 70-812259 or emailing chanceassociation@gmail.com
See the full agenda and program details.

Radiotherapy Challenges in Locally Advanced NSCLC in the Neoadjuvant Era
2026-02-26
The International Association for the Study of Lung Cancer (IASLC) is hosting a webinar on February 26, 2026, titled “Radiotherapy Challenges in Locally Advanced Non-Small Cell Lung Cancer in the Neoadjuvant Era.”
As Stage III NSCLC becomes a “moving target” due to the rapid integration of neoadjuvant chemo-immunotherapy, this session aims to bridge critical practice gaps in multidisciplinary care. Led by world-renowned experts including Shankar Siva (Peter MacCallum Cancer Centre), Cecile Le Pechoux (Gustave Roussy), and Paul Martin Putora (St. Gallen), the webinar will provide pragmatic strategies for navigating contemporary mediastinal staging, transitioning to definitive chemoradiotherapy when surgery is aborted, and optimizing post-operative radiation. By synthesizing evidence-based principles with case-based discussions, the event offers a vital framework for clinicians to deliver quality, risk-adapted care in an increasingly complex therapeutic landscape.
Register now.

2026 ASCO GU Cancers Symposium
2026-02-26 - 2026-02-28 | Moscone West, 800 Howard Street, San Francisco, United States
The 2026 ASCO Genitourinary (GU) Cancers Symposium is scheduled to take place from February 26 to 28, 2026, at Moscone West in San Francisco, California.
This premier event, hosted by the American Society of Clinical Oncology (ASCO), will focus on the latest advancements in the prevention, diagnosis, and treatment of genitourinary cancers, including prostate, bladder, kidney, and testicular cancers. The symposium will feature groundbreaking research presentations, expert-led educational sessions, and in-depth discussions on key topics in GU oncology.
Attendees can expect a rich program that combines plenary lectures, oral abstract presentations, poster sessions, and interactive workshops. The event emphasizes multidisciplinary collaboration, bringing together medical oncologists, urologists, radiation oncologists, pathologists, advanced practice providers, nurses, and patient advocates to discuss best practices and evolving treatment paradigms. Special focus sessions will cover precision oncology, immunotherapy, novel targeted therapies, survivorship, and health equity in GU cancers, highlighting both scientific innovation and patient-centered care.
The symposium also offers networking opportunities with leading global experts, enabling participants to exchange knowledge, discuss challenges, and foster collaborations that advance GU oncology. Both in-person and virtual attendance options are available, allowing wider access for international participants.
Registration.
You can find more posts featuring ASCO on OncoDaily.

2026 Translating Evidence to Action: Elevating Cancer Care
2026-02-26 09:00 - 17:00 (America/Halifax)
The “2026 Translating Evidence to Action: Elevating Cancer Care“ is an annual continuing medical education (CME) forum organized by Memorial Sloan Kettering Cancer Center (MSK), scheduled as a live virtual conference on Thursday, February 26, 2026.
This program is designed for healthcare professionals across all disciplines to explore how evidence-based research can be translated into meaningful quality improvements in clinical practice and patient outcomes. The conference features exemplary quality improvement projects, practice-based initiatives, two dynamic Rapid-Fire Poster Sessions, and a keynote address on “Technology with a Human Pulse: Advancing Patient Care with Innovation and Intention.” Participants can earn up to 6.50 AMA PRA Category 1 Credits.
Register.

Updates on Advanced Breast Cancer: Local Management and Other New Perspectives
2026-02-27 - 2026-02-28 | Houston Marriott Medical Center/Museum District, 6580 Fannin Street, Driveway Entrance on, 1730 Dryden Rd, Houston, TX, 77030, United States
The Updates on Advanced Breast Cancer: Local Management and Other New Perspectives conference is a one-and-a-half-day, in-person event scheduled for February 27–28, 2026, at the Houston Marriott Medical Center in Houston, TX.
Hosted by The University of Texas MD Anderson Cancer Center, the activity’s main goal is to emphasize the integration of novel therapies and diagnostic tools into clinical practice, focusing on areas like liquid biopsy, ctDNA, and MRD monitoring for inflammatory breast cancer (IBC).
Register.

5th Annual International Congress on Pediatric Oncology 2026
2026-02-27 08:00 - 17:00 (America/Halifax)
The 5th Annual International Congress on Pediatric Oncology will be held virtually on November 6, 2026.
Chaired by Dr. Jacqueline M. Kraveka of the Medical University of South Carolina, this congress focuses on the rapid evolution of pediatric solid and hematologic malignancies. The program highlights clinical trial interpretations regarding novel targeted agents and immunotherapies, alongside new techniques for molecular tumor characterization to improve outcomes for pediatric and adolescent/young adult (AYA) patients. Key highlights include focused sessions on navigating challenges in relapsed/refractory neuroblastoma, the integration of CAR-T cell therapies, and innovative strategies for managing late effects of treatment in survivorship care.
Register now.

Outcomes of Adolescent and Young Adult Patients with AML Treated on Adult Versus Pediatric Protocols - Resonance
2026-02-27 09:00 - 10:00 (America/New_York)
The ALRCaN Global webinar, titled “Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols,” is scheduled for Friday, February 27, 2026, at 09:00 AM ET.
Featuring Dr. Ira Kraft, the session will explore the comparative therapeutic outcomes for Adolescent and Young Adult (AYA) patients with Acute Myeloid Leukemia (AML) based on the clinical protocol used. Organized by Resonance Health and created by Ivana Cáceres, the event is supported by the leadership team of Scott Howard, Stacy Cooper, Archie Bleyer, and Dan Douer. This discussion provides a vital platform for the global medical community to evaluate the nuances between adult and pediatric treatment frameworks and their specific impact on the AYA population.

Lung Cancer Voices Summit 2026
2026-03-01 - 2026-03-03 | Hilton Washington DC Capitol Hill, 525 New Jersey Ave NW, Washington, D.C., DC, 20001, United States
The Lung Cancer Voices Summit, organized by GO2 for Lung Cancer, is a premier advocacy event scheduled for March 1–3, 2026, in Washington, D.C. As the largest annual meeting of its kind, it unites patients, caregivers, and medical professionals for a comprehensive program of education and direct advocacy on Capitol Hill.
The summit empowers participants to share their personal stories with federal lawmakers to champion increased research funding and policies that ensure affordable, high-quality healthcare for the lung cancer community.
Register.

Call-on Congress by Fight Colorectal Cancer
2026-03-01 17:00 - 2026-03-03 21:00 (America/Halifax) | Hilton Arlington National Landing, 2399 Richmond Highway Arlington, VA 22202 United States, Arlington, VA, 22202, United States
Now in its 20th year, Call-on Congress is Fight Colorectal Cancer’s (Fight CRC) signature advocacy event – founded on Nancy Roach’s belief that patients must have a seat at the policy table. Each year, patients, survivors, caregivers, and healthcare professionals gather in Washington, D.C. to meet with lawmakers, share their stories, and drive policy change.
Registration Includes:

Fight CRC swag bag
Virtual and in-person advocacy training
Exclusive advocacy resources
Scheduled congressional meetings
Meals (Mon: breakfast and lunch | Tue: breakfast and dinner)

Preparation Tips:

Review training materials and key talking points in advance
Join the Community of Champions for updates, hotel info, and volunteer opportunities
Wear blue! Casual for training, business casual for Capitol Hill, and comfortable shoes

Hotel and Scholarships:
Discounted hotel rooms are available for $185/night.
Scholarships are offered to make attendance accessible:

Advocate Travel Scholarship for adults
Junior Advocate Leadership Scholarship for youth (ages 13–18) and a parent/guardian.

You can find more posts featuring Fight Colorectal Cancer.

The Prevent Breast Cancer Research Conference
2026-03-03 - 2026-03-04 | Treehouse Hotel Manchester, Blackfriars St, Manchester, Manchester, Greater Manchester, M3 2EQ, United Kingdom
The Prevent Breast Cancer Research Conference 2026 is a two-day scientific symposium focused on the clinical and translational aspects of breast cancer risk assessment, early detection, and prevention strategies. Scheduled for March 3–4, 2026, in Manchester, the event features technical presentations on genomic risk prediction, hormonal signaling, and health inequalities in screening.
The program is structured for clinicians and researchers, incorporating a £10,000 “Dragons’ Den” research grant competition and a peer-reviewed poster session to highlight emerging data in the field of preventative oncology.

ESMO Deep Dive: Genitourinary Cancers : Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026
2026-03-04
The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC).
Scheduled for March 4, 2026, this virtual session focuses on the technical challenges of managing advanced disease where cure is no longer the primary objective, emphasizing the optimization of medical care through personalized treatment sequencing. This educational event, chaired by Michiel S. van der Heijden, is part of the ESMO Deep Dive series, which utilizes evidence-based data and expert-led discussion to refine clinical decision-making for complex genitourinary oncological cases.
Register.

ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich
2026-03-04 - 2026-03-05 | Zurich, Switzerland
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer.
The event is scheduled to take place on March 4–5, 2026, in Zurich, Switzerland.
The application deadline for participation is January 7, 2026, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing, using results for optimal patient selection, and discussing the proactive management of precision-medicine-based treatments.
Apply.

International Conference on Oncology, Cardiology and Critical Care Strategies (ICOCCS 2026)
2026-03-05 - 2026-03-06 | Shinjuku
The Institute for Global Academic Excellence (IGAE) is set to host the International Conference on Oncology, Cardiology and Critical Care Strategies (ICOCCS-26) from March 5–6, 2026, in Manchester, UK.
Operating in a hybrid mode to facilitate global participation, this multidisciplinary summit serves as a prestigious platform for scholars and healthcare professionals to converge on the intersections of three vital medical fields. The 2026 program is specifically designed to drive interdisciplinary collaboration, showcasing groundbreaking research and emerging technological methodologies that address complex clinical challenges. By fostering a high-level dialogue between academia and industry, ICOCCS-26 aims to accelerate the translation of innovative strategies into global practice while providing a robust platform for research publication in indexed journals.
Register.
